Sectra AB (publ) (STO:SECT.B)
Sweden · Delayed Price · Currency is SEK 302.00
-0.20 (-0.07%)
At close: Jun 12, 2026
Sectra AB Market Cap
Sectra AB has a market cap or net worth of 58.19 billion as of June 12, 2026. Its market cap has decreased by -3.51% in one year.
Market Cap
58.19B
Enterprise Value
56.45B
Revenue
3.64B
Ranking
n/a
PE Ratio
103.21
Stock Price
302.00
Market Cap Chart
Since March 3, 1999, Sectra AB's market cap has increased from 419.36M to 58.19B, an increase of 13,774.98%. That is a compound annual growth rate of 19.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 58.19B | 20.32% |
| Dec 30, 2025 | 48.36B | -9.27% |
| Dec 30, 2024 | 53.30B | 53.47% |
| Dec 29, 2023 | 34.73B | 21.15% |
| Dec 30, 2022 | 28.67B | -25.66% |
| Dec 30, 2021 | 38.56B | 36.47% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Getinge AB | 53.45B |
| Elekta AB | 20.02B |
| Nolato AB | 13.19B |
| Vitrolife AB | 12.97B |
| Xvivo Perfusion AB | 8.60B |
| MedCap AB | 7.47B |
| CellaVision AB | 3.30B |
| Devyser Diagnostics AB | 1.51B |